Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Amprenavir structure-based design

HiV-i protease Structure-based design aimed at reducing inhibitor size while maintaining sub-nanomolar potency led to the discovery of Amprenavir, a marketed anti-HIV-1 protease drug. 177... [Pg.629]

See other pages where Amprenavir structure-based design is mentioned: [Pg.381] [Pg.516] [Pg.274] [Pg.110] [Pg.942] [Pg.542] [Pg.199] [Pg.219] [Pg.119] [Pg.53] [Pg.199]

See also in sourсe #XX -- [ Pg.440 , Pg.441 ]

See also in sourсe #XX -- [ Pg.440 , Pg.441 ]

SEARCH

Amprenavir

Design Bases

Design structures

Structure based design

Structure designable